|
Recent Developments |
|
29-JUL-10
Marksans Pharma announced that it has entered into a Business Transfer Agreement with Kores (India) for sale and transfer of its Active Pharmaceutical Ingredient (API) business together with the manufacturing facilities located at Daund district in Pune, Maharashtra as a going concern on the terms and conditions as set out in the agreement.
29-DEC-09
The board of directors of Marksans Pharma at its meeting held on Dec. 29, 2009, has ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2014(12) | 31-Mar-2013(12) | 31-Mar-2012 (12) | | Net sales | 0.00 | 4.78 | 11.00 | | Other Income | 1.80 | 17.59 | 27.57 | | Total Income | 1.80 | 22.37 | 38.57 | | Cost of goods sold | 11.91 | 51.31 | 55.67 | | OPBDIT | -10.11 | -28.94 | -17.10 | | PAT | -18.03 | -39.22 | -22.25 | | Gross Block | - | - | - | | Equity capital | 393.35 | - | 393.35 | | EPS (Rs.) | - | - | -0.11 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -561.7 | -129.4 | -44.3 | | Net margin (% of OI) | -1001.7 | -175.3 | -57.7 |
|
|
Detailed Financials
|
|
|
|
|
